Bill > HR5582

This bill directs the Secretary of Health and Human Services to conduct a study and submit a report to Congress on the barriers to accessing abuse-deterrent opioid formulations for individuals enrolled in Medicare Part C (Medicare Advantage) or Part D (prescription drug) plans. The study will examine factors such as cost-sharing tiers, fail-first requirements, pricing, and prior authorization requirements that may be preventing individuals with chronic pain from accessing these abuse-deterrent opioid formulations. Abuse-deterrent opioid formulations refer to opioids that have features designed to prevent abuse, such as physical or chemical barriers, agonist or antagonist combinations, aversion properties, or delivery system mechanisms.

Budget and Finance, Business and Industry, Health and Social Services

https://www.congress.gov/bill/115th-congress/house-bill/5582/all-info